These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21188835)

  • 1. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?
    Szelényi Z
    J Appl Physiol (1985); 2010 Dec; 109(6):2008-9. PubMed ID: 21188835
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation is the dominant contributor to systemic hypertension.
    Fu Q; Levine BD
    J Appl Physiol (1985); 2010 Dec; 109(6):2012. PubMed ID: 21188802
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation: cause or consequence of hypertension?
    Campos RR; Bergamaschi CT
    J Appl Physiol (1985); 2010 Dec; 109(6):2013-4. PubMed ID: 21188830
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE; Negrao MV
    J Appl Physiol (1985); 2010 Dec; 109(6):2006. PubMed ID: 21188817
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Goldstein DS
    J Appl Physiol (1985); 2010 Dec; 109(6):2005-6. PubMed ID: 21188816
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Head GA; Burke SL
    J Appl Physiol (1985); 2010 Dec; 109(6):2010. PubMed ID: 21188825
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. The dominant mechanism depends on individual circumstance.
    Mathai ML
    J Appl Physiol (1985); 2010 Dec; 109(6):2011. PubMed ID: 21188826
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Hung jury?
    Bie P; Damkjaer M
    J Appl Physiol (1985); 2010 Dec; 109(6):2011. PubMed ID: 21188841
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. The role of the sympathetic nervous system--influences of sex and aging.
    Charkoudian N; Hart EC; Barnes JN; Joyner MJ
    J Appl Physiol (1985); 2010 Dec; 109(6):2005. PubMed ID: 21188833
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Li P
    J Appl Physiol (1985); 2010 Dec; 109(6):2008. PubMed ID: 21188819
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic nervous system, plasma volume, and hypertension.
    Christensen NJ
    J Appl Physiol (1985); 2010 Dec; 109(6):2003. PubMed ID: 21188813
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Zhao D
    J Appl Physiol (1985); 2010 Dec; 109(6):2010. PubMed ID: 21188837
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Remodeling of central sympathetic circuits precedes the development of hypertension.
    Murphy MN
    J Appl Physiol (1985); 2010 Dec; 109(6):2011-2. PubMed ID: 21188827
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Chronic activation of sympathetic nervous system and systemic hypertension--stress shows the way.
    Fontes MA; Xavier CH
    J Appl Physiol (1985); 2010 Dec; 109(6):2004-5. PubMed ID: 21188815
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Cowley AW
    J Appl Physiol (1985); 2010 Dec; 109(6):2009-10. PubMed ID: 21188824
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Dominant contributors for systemic hypertension--who leads, who follows?
    Braga VA
    J Appl Physiol (1985); 2010 Dec; 109(6):2007-8. PubMed ID: 21188840
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Carotid stimulation studies support a prominent role for the sympathetic nervous system.
    Wehrwein EA
    J Appl Physiol (1985); 2010 Dec; 109(6):2009. PubMed ID: 21188821
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. The kidney is not always the target in neurogenic hypertension.
    Osborn JW; Fink GD
    J Appl Physiol (1985); 2010 Dec; 109(6):2008. PubMed ID: 21188820
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--a "ratologist" point of view.
    Julien C
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188799
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Rohrwasser A
    J Appl Physiol (1985); 2010 Dec; 109(6):2007. PubMed ID: 21188818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.